This potential new indication could elevate bexarotine to major blockbuster level if there is any promise shown in human trials, and while I have no idea how quickly data might begin to come in, it seems intuitive that a drug already on the market could be "fast tracked" rather easily. Any positive trials, official or unofficial, will likely spread like wildfire across the internet. The valuation on a truly effective Alzheimer's treatment would be mind boggling. (no pun intended)
I am only expressing my personal opinions or repeating public information from SEC filings or media outlets-which may or may not be correct. Do your own investigating before investing!